The summit convenes prostate cancer survivors and medical, community, industry and policy
leaders to address issues towards eliminating the prostate cancer racial disparity. 

The Summit Is Free and Open to The Public 

Thursday, September 12th, 2019

Washington Court  Hotel
525 New Jersey Ave., NW
Washington, DC  20001
  Friday, September 13th, 2019

Washington Convention Center
801 Mt. Vernon Pl., NW
Washington, DC  20001

Summit Program Agenda Topics

I. New developments in prostate cancer treatment

Advances in prostate cancer therapies are providing patients with additional options to improve their treatment outcomes. Insights into some of these exciting advances highlighting patient impacts will be presented and discussed with medical and industry leaders.  

II. The increasing role of genetics and biomarkers

Genetic and genomic biomarker testing are playing an increasingly important role in helping patients assess their prostate cancer risks, and to personalize treatment selection including active surveillance. An understanding of these tests and how and why they are used will be presented.

III. Increasing African American Participation in Clinical Trials

Increasing African American participation in prostate cancer clinical trials is a PHEN priority. The FDA has issued draft guidance aimed at increasing diversity in clinical trials enrollment. This session will review this guidance, and efforts by PHEN and industry towards increasing diversity in prostate cancer trials.

IV. The African American Disparity - Biology or Access?

Recent studies and publications have indicated that the African American prostate cancer mortality disparity is due to unequal access to treatment as opposed to biological differences. This session will present and explore this new information and the implications.

V. PHEN Educational Outreach Initiatives

PHEN's education and awareness initiatives continue to expand in scope and reach. This session will review these initiatives, their progress and future plans. This includes monthly webcasts, faith-based programs, the "Daddy's Boys" stage play, and plans to increase outreach to veterans.

VI.  Prostate Cancer Early Detection Screening - An Update

An update on the U. S. Preventive Services Task Force (USPSTF) early detection screening guidance. What have we learned and how have African American and other high-risk populations been impacted?

 A Special Summit Performance
With great success PHEN is touring the Broadway-Style Stage Play "Daddy's Boys" to cities around the country to raise prostate cancer education and awareness through entertainment. With music, drama and comedy the play tells the story of a widowed father and his sons coming together through fractured relationships when faced with prostate cancer. A special performance will be held as a summit finale. Tickets are free to those who register.
 Hosted at 
First Baptist Church of Highland Park 
Dr. Henry P. Davis, III, Pastor
Friday, September 13th at 7 PM
Doors open at 6:30
6801 Sheriff Rd
Landover, MD 29785

Sponsorships are available for 
Summit and play. 
For more information, email

PHEN,Inc. © 2019 All rights reserved